nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—ABCB1—melanoma	0.347	1	CbGaD
Desloratadine—CYP1A2—Carmustine—melanoma	0.134	0.267	CbGbCtD
Desloratadine—CYP1A2—Vemurafenib—melanoma	0.106	0.211	CbGbCtD
Desloratadine—CYP2D6—Vemurafenib—melanoma	0.087	0.174	CbGbCtD
Desloratadine—CYP1A2—Dacarbazine—melanoma	0.0809	0.162	CbGbCtD
Desloratadine—ABCB1—Dactinomycin—melanoma	0.0614	0.123	CbGbCtD
Desloratadine—ABCB1—Docetaxel—melanoma	0.0317	0.0633	CbGbCtD
Desloratadine—Rash maculo-papular—Vemurafenib—melanoma	0.00271	0.0226	CcSEcCtD
Desloratadine—Extrapyramidal disorder—Temozolomide—melanoma	0.00203	0.0169	CcSEcCtD
Desloratadine—Otitis media—Temozolomide—melanoma	0.00196	0.0163	CcSEcCtD
Desloratadine—Viral infection—Temozolomide—melanoma	0.00169	0.0141	CcSEcCtD
Desloratadine—Infestation NOS—Vemurafenib—melanoma	0.00167	0.0139	CcSEcCtD
Desloratadine—Infestation—Vemurafenib—melanoma	0.00167	0.0139	CcSEcCtD
Desloratadine—Hepatic enzyme increased—Temozolomide—melanoma	0.00161	0.0134	CcSEcCtD
Desloratadine—Connective tissue disorder—Vemurafenib—melanoma	0.00147	0.0123	CcSEcCtD
Desloratadine—Cardiac disorder—Vemurafenib—melanoma	0.00139	0.0116	CcSEcCtD
Desloratadine—Erythema—Vemurafenib—melanoma	0.00131	0.0109	CcSEcCtD
Desloratadine—Otitis media—Docetaxel—melanoma	0.0013	0.0109	CcSEcCtD
Desloratadine—Rhinorrhoea—Docetaxel—melanoma	0.00125	0.0104	CcSEcCtD
Desloratadine—Cough—Vemurafenib—melanoma	0.00114	0.00948	CcSEcCtD
Desloratadine—Myalgia—Vemurafenib—melanoma	0.00111	0.00925	CcSEcCtD
Desloratadine—Affect lability—Temozolomide—melanoma	0.00109	0.00908	CcSEcCtD
Desloratadine—Blood bilirubin increased—Docetaxel—melanoma	0.00107	0.00893	CcSEcCtD
Desloratadine—Anaphylactic shock—Vemurafenib—melanoma	0.00107	0.00887	CcSEcCtD
Desloratadine—Infection—Vemurafenib—melanoma	0.00106	0.00881	CcSEcCtD
Desloratadine—Mood swings—Temozolomide—melanoma	0.00105	0.00874	CcSEcCtD
Desloratadine—Nervous system disorder—Vemurafenib—melanoma	0.00104	0.0087	CcSEcCtD
Desloratadine—Breast disorder—Temozolomide—melanoma	0.001	0.00834	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00097	0.00808	CcSEcCtD
Desloratadine—Decreased appetite—Vemurafenib—melanoma	0.000926	0.00771	CcSEcCtD
Desloratadine—Bronchitis—Temozolomide—melanoma	0.000921	0.00767	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00092	0.00766	CcSEcCtD
Desloratadine—Fatigue—Vemurafenib—melanoma	0.000918	0.00765	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Temozolomide—melanoma	0.00089	0.00741	CcSEcCtD
Desloratadine—Urinary tract infection—Carmustine—melanoma	0.000858	0.00715	CcSEcCtD
Desloratadine—Infestation NOS—Temozolomide—melanoma	0.000853	0.00711	CcSEcCtD
Desloratadine—Infestation—Temozolomide—melanoma	0.000853	0.00711	CcSEcCtD
Desloratadine—Hepatitis—Dactinomycin—melanoma	0.000847	0.00706	CcSEcCtD
Desloratadine—Body temperature increased—Vemurafenib—melanoma	0.000842	0.00701	CcSEcCtD
Desloratadine—Pharyngitis—Dactinomycin—melanoma	0.000841	0.007	CcSEcCtD
Desloratadine—Urinary tract infection—Temozolomide—melanoma	0.00083	0.00691	CcSEcCtD
Desloratadine—Hepatobiliary disease—Temozolomide—melanoma	0.000807	0.00672	CcSEcCtD
Desloratadine—Erythema—Bleomycin—melanoma	0.000791	0.00659	CcSEcCtD
Desloratadine—Hallucination—Carmustine—melanoma	0.000789	0.00657	CcSEcCtD
Desloratadine—Hypersensitivity—Vemurafenib—melanoma	0.000785	0.00654	CcSEcCtD
Desloratadine—Connective tissue disorder—Carmustine—melanoma	0.000779	0.00649	CcSEcCtD
Desloratadine—Hepatitis—Temozolomide—melanoma	0.000766	0.00638	CcSEcCtD
Desloratadine—Asthenia—Vemurafenib—melanoma	0.000764	0.00636	CcSEcCtD
Desloratadine—Hallucination—Temozolomide—melanoma	0.000762	0.00635	CcSEcCtD
Desloratadine—Pharyngitis—Temozolomide—melanoma	0.00076	0.00633	CcSEcCtD
Desloratadine—Pruritus—Vemurafenib—melanoma	0.000754	0.00628	CcSEcCtD
Desloratadine—Connective tissue disorder—Temozolomide—melanoma	0.000753	0.00627	CcSEcCtD
Desloratadine—Erythema—Dactinomycin—melanoma	0.000737	0.00614	CcSEcCtD
Desloratadine—Diarrhoea—Vemurafenib—melanoma	0.000729	0.00607	CcSEcCtD
Desloratadine—Cardiac disorder—Temozolomide—melanoma	0.000711	0.00592	CcSEcCtD
Desloratadine—Dizziness—Vemurafenib—melanoma	0.000704	0.00587	CcSEcCtD
Desloratadine—Mental disorder—Carmustine—melanoma	0.000695	0.00579	CcSEcCtD
Desloratadine—Erythema—Carmustine—melanoma	0.00069	0.00575	CcSEcCtD
Desloratadine—Cough—Bleomycin—melanoma	0.00069	0.00575	CcSEcCtD
Desloratadine—Vomiting—Vemurafenib—melanoma	0.000677	0.00564	CcSEcCtD
Desloratadine—Myalgia—Bleomycin—melanoma	0.000673	0.00561	CcSEcCtD
Desloratadine—Rash—Vemurafenib—melanoma	0.000672	0.00559	CcSEcCtD
Desloratadine—Mental disorder—Temozolomide—melanoma	0.000671	0.00559	CcSEcCtD
Desloratadine—Dermatitis—Vemurafenib—melanoma	0.000671	0.00559	CcSEcCtD
Desloratadine—Headache—Vemurafenib—melanoma	0.000667	0.00556	CcSEcCtD
Desloratadine—Erythema—Temozolomide—melanoma	0.000667	0.00556	CcSEcCtD
Desloratadine—Breast disorder—Docetaxel—melanoma	0.000666	0.00554	CcSEcCtD
Desloratadine—Nasopharyngitis—Docetaxel—melanoma	0.000659	0.00549	CcSEcCtD
Desloratadine—Anaphylactic shock—Bleomycin—melanoma	0.000645	0.00537	CcSEcCtD
Desloratadine—Oedema—Bleomycin—melanoma	0.000645	0.00537	CcSEcCtD
Desloratadine—Infection—Bleomycin—melanoma	0.000641	0.00534	CcSEcCtD
Desloratadine—Agitation—Carmustine—melanoma	0.000634	0.00528	CcSEcCtD
Desloratadine—Nausea—Vemurafenib—melanoma	0.000633	0.00527	CcSEcCtD
Desloratadine—Myalgia—Dactinomycin—melanoma	0.000628	0.00523	CcSEcCtD
Desloratadine—Anorexia—Bleomycin—melanoma	0.000615	0.00512	CcSEcCtD
Desloratadine—Agitation—Temozolomide—melanoma	0.000613	0.0051	CcSEcCtD
Desloratadine—Angioedema—Temozolomide—melanoma	0.000609	0.00508	CcSEcCtD
Desloratadine—Oedema—Dactinomycin—melanoma	0.000602	0.00501	CcSEcCtD
Desloratadine—Convulsion—Carmustine—melanoma	0.000598	0.00498	CcSEcCtD
Desloratadine—Infection—Dactinomycin—melanoma	0.000598	0.00498	CcSEcCtD
Desloratadine—Palpitations—Temozolomide—melanoma	0.000589	0.00491	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000588	0.0049	CcSEcCtD
Desloratadine—Myalgia—Carmustine—melanoma	0.000588	0.00489	CcSEcCtD
Desloratadine—Cough—Temozolomide—melanoma	0.000582	0.00485	CcSEcCtD
Desloratadine—Convulsion—Temozolomide—melanoma	0.000578	0.00481	CcSEcCtD
Desloratadine—Dyspnoea—Bleomycin—melanoma	0.000575	0.00479	CcSEcCtD
Desloratadine—Anorexia—Dactinomycin—melanoma	0.000574	0.00478	CcSEcCtD
Desloratadine—Myalgia—Temozolomide—melanoma	0.000568	0.00473	CcSEcCtD
Desloratadine—Infestation NOS—Docetaxel—melanoma	0.000568	0.00473	CcSEcCtD
Desloratadine—Infestation—Docetaxel—melanoma	0.000568	0.00473	CcSEcCtD
Desloratadine—Oedema—Carmustine—melanoma	0.000563	0.00469	CcSEcCtD
Desloratadine—Decreased appetite—Bleomycin—melanoma	0.000561	0.00467	CcSEcCtD
Desloratadine—Infection—Carmustine—melanoma	0.00056	0.00466	CcSEcCtD
Desloratadine—Dry mouth—Temozolomide—melanoma	0.000555	0.00463	CcSEcCtD
Desloratadine—Tachycardia—Carmustine—melanoma	0.00055	0.00458	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000548	0.00457	CcSEcCtD
Desloratadine—Anaphylactic shock—Temozolomide—melanoma	0.000544	0.00453	CcSEcCtD
Desloratadine—Oedema—Temozolomide—melanoma	0.000544	0.00453	CcSEcCtD
Desloratadine—Infection—Temozolomide—melanoma	0.000541	0.0045	CcSEcCtD
Desloratadine—Anorexia—Carmustine—melanoma	0.000537	0.00447	CcSEcCtD
Desloratadine—Hepatobiliary disease—Docetaxel—melanoma	0.000537	0.00447	CcSEcCtD
Desloratadine—Epistaxis—Docetaxel—melanoma	0.000535	0.00446	CcSEcCtD
Desloratadine—Nervous system disorder—Temozolomide—melanoma	0.000534	0.00445	CcSEcCtD
Desloratadine—Decreased appetite—Dactinomycin—melanoma	0.000523	0.00436	CcSEcCtD
Desloratadine—Fatigue—Dactinomycin—melanoma	0.000519	0.00432	CcSEcCtD
Desloratadine—Anorexia—Temozolomide—melanoma	0.000519	0.00432	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Carmustine—melanoma	0.000513	0.00427	CcSEcCtD
Desloratadine—Urticaria—Bleomycin—melanoma	0.000513	0.00427	CcSEcCtD
Desloratadine—Body temperature increased—Bleomycin—melanoma	0.00051	0.00425	CcSEcCtD
Desloratadine—Hepatitis—Docetaxel—melanoma	0.00051	0.00424	CcSEcCtD
Desloratadine—Insomnia—Carmustine—melanoma	0.000509	0.00424	CcSEcCtD
Desloratadine—Pharyngitis—Docetaxel—melanoma	0.000506	0.00421	CcSEcCtD
Desloratadine—Dyspnoea—Carmustine—melanoma	0.000502	0.00418	CcSEcCtD
Desloratadine—Somnolence—Carmustine—melanoma	0.000501	0.00417	CcSEcCtD
Desloratadine—Connective tissue disorder—Docetaxel—melanoma	0.000501	0.00417	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000496	0.00413	CcSEcCtD
Desloratadine—Insomnia—Temozolomide—melanoma	0.000492	0.0041	CcSEcCtD
Desloratadine—Gastrointestinal pain—Dactinomycin—melanoma	0.000492	0.0041	CcSEcCtD
Desloratadine—Decreased appetite—Carmustine—melanoma	0.00049	0.00408	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Carmustine—melanoma	0.000486	0.00405	CcSEcCtD
Desloratadine—Dyspnoea—Temozolomide—melanoma	0.000485	0.00404	CcSEcCtD
Desloratadine—Somnolence—Temozolomide—melanoma	0.000484	0.00403	CcSEcCtD
Desloratadine—Dyspepsia—Temozolomide—melanoma	0.000479	0.00399	CcSEcCtD
Desloratadine—Body temperature increased—Dactinomycin—melanoma	0.000476	0.00396	CcSEcCtD
Desloratadine—Abdominal pain—Dactinomycin—melanoma	0.000476	0.00396	CcSEcCtD
Desloratadine—Hypersensitivity—Bleomycin—melanoma	0.000475	0.00396	CcSEcCtD
Desloratadine—Decreased appetite—Temozolomide—melanoma	0.000473	0.00394	CcSEcCtD
Desloratadine—Cardiac disorder—Docetaxel—melanoma	0.000473	0.00394	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Temozolomide—melanoma	0.00047	0.00391	CcSEcCtD
Desloratadine—Fatigue—Temozolomide—melanoma	0.000469	0.00391	CcSEcCtD
Desloratadine—Asthenia—Bleomycin—melanoma	0.000463	0.00386	CcSEcCtD
Desloratadine—Gastrointestinal pain—Carmustine—melanoma	0.000461	0.00384	CcSEcCtD
Desloratadine—Pruritus—Bleomycin—melanoma	0.000457	0.0038	CcSEcCtD
Desloratadine—Mental disorder—Docetaxel—melanoma	0.000446	0.00372	CcSEcCtD
Desloratadine—Body temperature increased—Carmustine—melanoma	0.000445	0.00371	CcSEcCtD
Desloratadine—Abdominal pain—Carmustine—melanoma	0.000445	0.00371	CcSEcCtD
Desloratadine—Gastrointestinal pain—Temozolomide—melanoma	0.000445	0.00371	CcSEcCtD
Desloratadine—Erythema—Docetaxel—melanoma	0.000444	0.00369	CcSEcCtD
Desloratadine—Hypersensitivity—Dactinomycin—melanoma	0.000443	0.00369	CcSEcCtD
Desloratadine—Urticaria—Temozolomide—melanoma	0.000432	0.0036	CcSEcCtD
Desloratadine—Asthenia—Dactinomycin—melanoma	0.000432	0.0036	CcSEcCtD
Desloratadine—Abdominal pain—Temozolomide—melanoma	0.00043	0.00358	CcSEcCtD
Desloratadine—Body temperature increased—Temozolomide—melanoma	0.00043	0.00358	CcSEcCtD
Desloratadine—Hypersensitivity—Carmustine—melanoma	0.000415	0.00346	CcSEcCtD
Desloratadine—Diarrhoea—Dactinomycin—melanoma	0.000412	0.00343	CcSEcCtD
Desloratadine—Vomiting—Bleomycin—melanoma	0.00041	0.00342	CcSEcCtD
Desloratadine—Rash—Bleomycin—melanoma	0.000407	0.00339	CcSEcCtD
Desloratadine—Dermatitis—Bleomycin—melanoma	0.000406	0.00339	CcSEcCtD
Desloratadine—Asthenia—Carmustine—melanoma	0.000404	0.00337	CcSEcCtD
Desloratadine—Hypersensitivity—Temozolomide—melanoma	0.000401	0.00334	CcSEcCtD
Desloratadine—Palpitations—Docetaxel—melanoma	0.000392	0.00326	CcSEcCtD
Desloratadine—Asthenia—Temozolomide—melanoma	0.000391	0.00325	CcSEcCtD
Desloratadine—Cough—Docetaxel—melanoma	0.000387	0.00322	CcSEcCtD
Desloratadine—Diarrhoea—Carmustine—melanoma	0.000385	0.00321	CcSEcCtD
Desloratadine—Pruritus—Temozolomide—melanoma	0.000385	0.00321	CcSEcCtD
Desloratadine—Convulsion—Docetaxel—melanoma	0.000384	0.0032	CcSEcCtD
Desloratadine—Nausea—Bleomycin—melanoma	0.000383	0.00319	CcSEcCtD
Desloratadine—Vomiting—Dactinomycin—melanoma	0.000383	0.00319	CcSEcCtD
Desloratadine—Rash—Dactinomycin—melanoma	0.000379	0.00316	CcSEcCtD
Desloratadine—Myalgia—Docetaxel—melanoma	0.000378	0.00315	CcSEcCtD
Desloratadine—Dizziness—Carmustine—melanoma	0.000372	0.0031	CcSEcCtD
Desloratadine—Diarrhoea—Temozolomide—melanoma	0.000372	0.0031	CcSEcCtD
Desloratadine—Dry mouth—Docetaxel—melanoma	0.000369	0.00308	CcSEcCtD
Desloratadine—Oedema—Docetaxel—melanoma	0.000362	0.00301	CcSEcCtD
Desloratadine—Anaphylactic shock—Docetaxel—melanoma	0.000362	0.00301	CcSEcCtD
Desloratadine—Dizziness—Temozolomide—melanoma	0.00036	0.003	CcSEcCtD
Desloratadine—Infection—Docetaxel—melanoma	0.00036	0.003	CcSEcCtD
Desloratadine—Vomiting—Carmustine—melanoma	0.000358	0.00298	CcSEcCtD
Desloratadine—Nausea—Dactinomycin—melanoma	0.000357	0.00298	CcSEcCtD
Desloratadine—Rash—Carmustine—melanoma	0.000355	0.00296	CcSEcCtD
Desloratadine—Nervous system disorder—Docetaxel—melanoma	0.000355	0.00296	CcSEcCtD
Desloratadine—Dermatitis—Carmustine—melanoma	0.000355	0.00296	CcSEcCtD
Desloratadine—Tachycardia—Docetaxel—melanoma	0.000353	0.00294	CcSEcCtD
Desloratadine—Headache—Carmustine—melanoma	0.000353	0.00294	CcSEcCtD
Desloratadine—Vomiting—Temozolomide—melanoma	0.000346	0.00288	CcSEcCtD
Desloratadine—Anorexia—Docetaxel—melanoma	0.000345	0.00287	CcSEcCtD
Desloratadine—Rash—Temozolomide—melanoma	0.000343	0.00286	CcSEcCtD
Desloratadine—Dermatitis—Temozolomide—melanoma	0.000343	0.00286	CcSEcCtD
Desloratadine—Headache—Temozolomide—melanoma	0.000341	0.00284	CcSEcCtD
Desloratadine—Nausea—Carmustine—melanoma	0.000335	0.00279	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Docetaxel—melanoma	0.00033	0.00275	CcSEcCtD
Desloratadine—Insomnia—Docetaxel—melanoma	0.000327	0.00273	CcSEcCtD
Desloratadine—Nausea—Temozolomide—melanoma	0.000323	0.00269	CcSEcCtD
Desloratadine—Dyspnoea—Docetaxel—melanoma	0.000323	0.00269	CcSEcCtD
Desloratadine—Somnolence—Docetaxel—melanoma	0.000322	0.00268	CcSEcCtD
Desloratadine—Dyspepsia—Docetaxel—melanoma	0.000319	0.00265	CcSEcCtD
Desloratadine—Decreased appetite—Docetaxel—melanoma	0.000315	0.00262	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Docetaxel—melanoma	0.000313	0.0026	CcSEcCtD
Desloratadine—Fatigue—Docetaxel—melanoma	0.000312	0.0026	CcSEcCtD
Desloratadine—Gastrointestinal pain—Docetaxel—melanoma	0.000296	0.00247	CcSEcCtD
Desloratadine—Body temperature increased—Docetaxel—melanoma	0.000286	0.00238	CcSEcCtD
Desloratadine—Abdominal pain—Docetaxel—melanoma	0.000286	0.00238	CcSEcCtD
Desloratadine—Hypersensitivity—Docetaxel—melanoma	0.000267	0.00222	CcSEcCtD
Desloratadine—Asthenia—Docetaxel—melanoma	0.00026	0.00216	CcSEcCtD
Desloratadine—Pruritus—Docetaxel—melanoma	0.000256	0.00213	CcSEcCtD
Desloratadine—Diarrhoea—Docetaxel—melanoma	0.000248	0.00206	CcSEcCtD
Desloratadine—Dizziness—Docetaxel—melanoma	0.000239	0.00199	CcSEcCtD
Desloratadine—Vomiting—Docetaxel—melanoma	0.00023	0.00192	CcSEcCtD
Desloratadine—Rash—Docetaxel—melanoma	0.000228	0.0019	CcSEcCtD
Desloratadine—Dermatitis—Docetaxel—melanoma	0.000228	0.0019	CcSEcCtD
Desloratadine—Headache—Docetaxel—melanoma	0.000227	0.00189	CcSEcCtD
Desloratadine—Nausea—Docetaxel—melanoma	0.000215	0.00179	CcSEcCtD
Desloratadine—CYP2D6—Metabolism—BSG—melanoma	1.35e-05	0.000419	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CSPG4—melanoma	1.35e-05	0.000419	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.35e-05	0.000419	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SDHD—melanoma	1.34e-05	0.000416	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—BSG—melanoma	1.34e-05	0.000416	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CSPG4—melanoma	1.34e-05	0.000416	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CSF2—melanoma	1.34e-05	0.000415	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.33e-05	0.000411	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GPAM—melanoma	1.31e-05	0.000406	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—RAC1—melanoma	1.31e-05	0.000406	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GPAM—melanoma	1.3e-05	0.000403	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.3e-05	0.000402	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.3e-05	0.000402	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PRKCA—melanoma	1.28e-05	0.000398	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAP2K2—melanoma	1.26e-05	0.000389	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.23e-05	0.000382	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PHGDH—melanoma	1.23e-05	0.000382	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—LUM—melanoma	1.23e-05	0.000382	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—F2R—melanoma	1.23e-05	0.00038	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.22e-05	0.000379	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PLA2G6—melanoma	1.21e-05	0.000375	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HPSE—melanoma	1.21e-05	0.000375	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—RAC1—melanoma	1.19e-05	0.000369	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EDNRB—melanoma	1.19e-05	0.000368	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CUBN—melanoma	1.19e-05	0.000368	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PLA2G6—melanoma	1.18e-05	0.000366	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTK2B—melanoma	1.15e-05	0.000358	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SDHD—melanoma	1.15e-05	0.000355	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—BSG—melanoma	1.15e-05	0.000355	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CSPG4—melanoma	1.15e-05	0.000355	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.13e-05	0.000348	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GAB2—melanoma	1.12e-05	0.000348	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GNA11—melanoma	1.12e-05	0.000348	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FLT1—melanoma	1.12e-05	0.000346	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PLA2G6—melanoma	1.11e-05	0.000345	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GPAM—melanoma	1.11e-05	0.000344	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CG—melanoma	1.11e-05	0.000343	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PLA2G6—melanoma	1.11e-05	0.000342	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—VCAN—melanoma	1.09e-05	0.000337	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.09e-05	0.000337	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—VCAN—melanoma	1.06e-05	0.000329	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FOXO4—melanoma	1.06e-05	0.000327	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCR4—melanoma	1.06e-05	0.000327	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HDAC2—melanoma	1.06e-05	0.000327	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GNAQ—melanoma	1.04e-05	0.000323	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.03e-05	0.000319	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CG—melanoma	1.01e-05	0.000311	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—VCAN—melanoma	1e-05	0.00031	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.95e-06	0.000308	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—VCAN—melanoma	9.93e-06	0.000307	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SYK—melanoma	9.81e-06	0.000304	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CD—melanoma	9.74e-06	0.000302	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ITGAV—melanoma	9.63e-06	0.000298	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NGFR—melanoma	9.63e-06	0.000298	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AKT3—melanoma	9.63e-06	0.000298	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PLA2G6—melanoma	9.44e-06	0.000292	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.4e-06	0.000291	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	9.19e-06	0.000285	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP17A1—melanoma	9.19e-06	0.000284	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.07e-06	0.000281	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.06e-06	0.000281	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP17A1—melanoma	8.97e-06	0.000278	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	8.94e-06	0.000277	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SOCS1—melanoma	8.92e-06	0.000276	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAP2K1—melanoma	8.9e-06	0.000276	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—S100B—melanoma	8.9e-06	0.000276	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CD—melanoma	8.84e-06	0.000274	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GNA11—melanoma	8.67e-06	0.000269	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ERBB4—melanoma	8.51e-06	0.000264	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—FASN—melanoma	8.49e-06	0.000263	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CB—melanoma	8.49e-06	0.000263	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—VCAN—melanoma	8.48e-06	0.000263	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GNA11—melanoma	8.47e-06	0.000262	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP17A1—melanoma	8.45e-06	0.000262	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN2B—melanoma	8.44e-06	0.000261	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP17A1—melanoma	8.38e-06	0.000259	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—SLC5A5—melanoma	8.35e-06	0.000259	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	8.3e-06	0.000257	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—FASN—melanoma	8.29e-06	0.000257	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.26e-06	0.000256	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CD86—melanoma	8.16e-06	0.000253	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CXCL8—melanoma	8.15e-06	0.000253	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	8.15e-06	0.000253	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—SLC5A5—melanoma	8.15e-06	0.000252	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EDN1—melanoma	8.09e-06	0.000251	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CD44—melanoma	8.06e-06	0.00025	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GNAQ—melanoma	8.06e-06	0.00025	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.03e-06	0.000249	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GNA11—melanoma	7.98e-06	0.000247	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CSF2—melanoma	7.91e-06	0.000245	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGF1—melanoma	7.91e-06	0.000245	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GNA11—melanoma	7.91e-06	0.000245	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.9e-06	0.000245	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GNAQ—melanoma	7.87e-06	0.000244	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CD44—melanoma	7.87e-06	0.000244	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.82e-06	0.000242	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—FASN—melanoma	7.81e-06	0.000242	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—IL2—melanoma	7.79e-06	0.000241	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.75e-06	0.00024	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—E2F1—melanoma	7.74e-06	0.00024	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—FASN—melanoma	7.74e-06	0.00024	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP1B1—melanoma	7.73e-06	0.000239	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CB—melanoma	7.71e-06	0.000239	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—SLC5A5—melanoma	7.68e-06	0.000238	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PDGFRA—melanoma	7.66e-06	0.000237	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SLC5A5—melanoma	7.61e-06	0.000236	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ITGB3—melanoma	7.58e-06	0.000235	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PRKCA—melanoma	7.58e-06	0.000235	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP1B1—melanoma	7.55e-06	0.000234	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SPP1—melanoma	7.44e-06	0.00023	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CD44—melanoma	7.42e-06	0.00023	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GNAQ—melanoma	7.42e-06	0.00023	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAP2K2—melanoma	7.41e-06	0.00023	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CXCL8—melanoma	7.41e-06	0.000229	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GNAQ—melanoma	7.35e-06	0.000228	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CD44—melanoma	7.35e-06	0.000228	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.2e-06	0.000223	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP17A1—melanoma	7.16e-06	0.000222	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.13e-06	0.000221	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP1B1—melanoma	7.11e-06	0.00022	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL2—melanoma	7.08e-06	0.000219	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.06e-06	0.000219	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TERT—melanoma	7.05e-06	0.000218	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP1B1—melanoma	7.05e-06	0.000218	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—RAC1—melanoma	7.03e-06	0.000218	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	6.97e-06	0.000216	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.82e-06	0.000211	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GNA11—melanoma	6.76e-06	0.000209	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HIF1A—melanoma	6.74e-06	0.000209	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—FASN—melanoma	6.61e-06	0.000205	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SLC5A5—melanoma	6.51e-06	0.000202	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KDR—melanoma	6.45e-06	0.0002	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ABCB1—melanoma	6.37e-06	0.000197	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GNAQ—melanoma	6.28e-06	0.000195	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CD44—melanoma	6.28e-06	0.000195	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.22e-06	0.000193	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FN1—melanoma	6.21e-06	0.000192	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.15e-06	0.000191	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.1e-06	0.000189	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NOTCH1—melanoma	6.08e-06	0.000188	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP1B1—melanoma	6.02e-06	0.000187	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CD80—melanoma	5.95e-06	0.000184	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APC—melanoma	5.94e-06	0.000184	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KIT—melanoma	5.94e-06	0.000184	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CG—melanoma	5.94e-06	0.000184	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—NRAS—melanoma	5.94e-06	0.000184	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EGF—melanoma	5.87e-06	0.000182	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PRKCA—melanoma	5.86e-06	0.000181	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ABCB1—melanoma	5.86e-06	0.000181	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ERCC2—melanoma	5.81e-06	0.00018	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ABCB1—melanoma	5.81e-06	0.00018	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PRKCA—melanoma	5.72e-06	0.000177	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAPK3—melanoma	5.69e-06	0.000176	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ERCC2—melanoma	5.67e-06	0.000176	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—BRAF—melanoma	5.58e-06	0.000173	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IGF1—melanoma	5.44e-06	0.000168	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAPK1—melanoma	5.41e-06	0.000168	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—EGFR—melanoma	5.41e-06	0.000168	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PRKCA—melanoma	5.39e-06	0.000167	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ERCC2—melanoma	5.34e-06	0.000166	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PRKCA—melanoma	5.34e-06	0.000165	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.32e-06	0.000165	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ERCC2—melanoma	5.3e-06	0.000164	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAP2K1—melanoma	5.26e-06	0.000163	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CD—melanoma	5.22e-06	0.000162	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CA—melanoma	5.17e-06	0.00016	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—KRAS—melanoma	5.11e-06	0.000158	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGF2—melanoma	5e-06	0.000155	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ABCB1—melanoma	4.96e-06	0.000154	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.81e-06	0.000149	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CA—melanoma	4.7e-06	0.000145	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MDM2—melanoma	4.68e-06	0.000145	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ERBB2—melanoma	4.61e-06	0.000143	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CG—melanoma	4.59e-06	0.000142	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PRKCA—melanoma	4.57e-06	0.000141	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CB—melanoma	4.55e-06	0.000141	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ERCC2—melanoma	4.53e-06	0.00014	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CG—melanoma	4.48e-06	0.000139	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PPARG—melanoma	4.43e-06	0.000137	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.39e-06	0.000136	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCL8—melanoma	4.37e-06	0.000135	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—HRAS—melanoma	4.35e-06	0.000135	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PPARG—melanoma	4.32e-06	0.000134	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN1B—melanoma	4.27e-06	0.000132	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—AKT1—melanoma	4.23e-06	0.000131	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CG—melanoma	4.22e-06	0.000131	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CASP3—melanoma	4.19e-06	0.00013	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CG—melanoma	4.18e-06	0.00013	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL2—melanoma	4.18e-06	0.000129	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL6—melanoma	4.16e-06	0.000129	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCND1—melanoma	4.08e-06	0.000126	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PPARG—melanoma	4.07e-06	0.000126	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PPARG—melanoma	4.04e-06	0.000125	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CTNNB1—melanoma	4.04e-06	0.000125	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CD—melanoma	4.03e-06	0.000125	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ALB—melanoma	3.98e-06	0.000123	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MMP9—melanoma	3.96e-06	0.000123	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN1A—melanoma	3.94e-06	0.000122	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CD—melanoma	3.94e-06	0.000122	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTEN—melanoma	3.93e-06	0.000122	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NFKB1—melanoma	3.91e-06	0.000121	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ALB—melanoma	3.89e-06	0.00012	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—AKT1—melanoma	3.84e-06	0.000119	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.75e-06	0.000116	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CD—melanoma	3.71e-06	0.000115	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CD—melanoma	3.68e-06	0.000114	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ALB—melanoma	3.66e-06	0.000113	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ALB—melanoma	3.63e-06	0.000112	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CG—melanoma	3.58e-06	0.000111	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—VEGFA—melanoma	3.55e-06	0.00011	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT3—melanoma	3.52e-06	0.000109	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CB—melanoma	3.52e-06	0.000109	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NRAS—melanoma	3.51e-06	0.000109	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTGS2—melanoma	3.48e-06	0.000108	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PPARG—melanoma	3.45e-06	0.000107	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CB—melanoma	3.43e-06	0.000106	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTGS2—melanoma	3.4e-06	0.000105	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK3—melanoma	3.36e-06	0.000104	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MYC—melanoma	3.27e-06	0.000101	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CB—melanoma	3.23e-06	0.0001	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CB—melanoma	3.21e-06	9.93e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTGS2—melanoma	3.2e-06	9.93e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK1—melanoma	3.2e-06	9.91e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EGFR—melanoma	3.2e-06	9.9e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTGS2—melanoma	3.18e-06	9.84e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CD—melanoma	3.14e-06	9.74e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALB—melanoma	3.1e-06	9.61e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTEN—melanoma	3.04e-06	9.41e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KRAS—melanoma	3.02e-06	9.36e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTEN—melanoma	2.97e-06	9.19e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTEN—melanoma	2.8e-06	8.66e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CA—melanoma	2.78e-06	8.6e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTEN—melanoma	2.77e-06	8.58e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CB—melanoma	2.74e-06	8.49e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTGS2—melanoma	2.72e-06	8.41e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TP53—melanoma	2.68e-06	8.32e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HRAS—melanoma	2.57e-06	7.95e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL6—melanoma	2.46e-06	7.61e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTEN—melanoma	2.37e-06	7.33e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AKT1—melanoma	2.27e-06	7.02e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CA—melanoma	2.14e-06	6.64e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CA—melanoma	2.09e-06	6.48e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CA—melanoma	1.97e-06	6.11e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CA—melanoma	1.95e-06	6.05e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—AKT1—melanoma	1.75e-06	5.42e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—AKT1—melanoma	1.71e-06	5.29e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CA—melanoma	1.67e-06	5.17e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—AKT1—melanoma	1.61e-06	4.99e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—AKT1—melanoma	1.6e-06	4.95e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—AKT1—melanoma	1.36e-06	4.23e-05	CbGpPWpGaD
